Home

DiaMedBase 

Diabetes Medicinal Plant Database

Browse    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     Plants List
Caesalpinia
Cajanus
Calamintha
Camellia
Capparis
Capsicum
Caralluma
Carissa
Carum
Casearia
Cassia
Castanospermum
Catharanthus
Cecropia
Centaurea
Centaurium
Cephalandra
Chamaemelum
Chelidonium
Chrysanthemum
Chrysobalanus
Cicer
Cichorium
Cimicifuga
Cinnamomum
Cirsium
Cissus
Citrullus
Citrus
Clausena
Cleome
Cnidium
Cnidoscolus
Coccinia
Cogniauxia
Colocassia
Commelina
Commiphora
Convallaria
Convolvulus
Coptis
Coriandrum
Corni
Cornus
Coscinium
Costus
Cressa
Crotalaria
Croton
Cryptolepis
Cucumis
Cucurbita
Cuminum
Curcuma
Cyamopsis
Cyclocarya
Cymbopogon
 
DiaMedBase ID   DMPCe140
Medicinal Plant   Luffa aegyptiaca  and Carissa edulis
Plant part(s)   Seeds and Leaves
Objective  

To investigate the effect of oral administration of the ethanolic extracts of Luffa aegyptiaca (seeds) and Carissa edulis (leaves) on blood glucose levels both in normal and streptozotocin (STZ) diabetic rats

Journal Source   J Ethnopharmacol. 1996; 50(1):43-47
Title  

Effect of Luffa aegyptiaca (seeds) and Carissa edulis (leaves) extracts on blood glucose level of normal and streptozotocin diabetic rats

Authors   El-Fiky FK, Abou-Karam MA, Afify EA.
Address   Department of Phalmacognosy, University of Alexandria, Egypt
Abstract  

The present study investigates the effect of oral administration of the ethanolic extracts of Luffa aegyptiaca (seeds) and Carissa edulis (leaves) on blood glucose levels both in normal and streptozotocin (STZ) diabetic rats. Treatment with both extracts significantly reduced the blood glucose level inSTZ diabetic rats during the first three hours of treatment. L. aegyptiaca extract decreased blood glucose level with a potency similar to that of the biguanide, metformin. The total glycaemic areas were 589.61 +/- 45.62 mg/dl/3 h and 660.38 +/- 64.44 mg/dl/3 h for L. aegyptiaca and metformin, respectively, vs. 816.73 +/- 43.21 mg/dl/3 h for the control (P < 0.05). On the other hand, in normal rats, both treatments produced insignificant changes in blood glucose levels compared to glibenclamide treatment.

Diseases   Disease Link

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

          Copyright © 2006 ProGene Biosciences
            Last modified: March, 2006
             info@progenebio.in